HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful ...
Characterized by weakened or damaged heart musculature, heart failure results in the gradual buildup of fluid in a patient's lungs, legs, feet, and other parts of the body. The condition is chronic ...
Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...
Myocardial ischemia, the primary driver of heart attacks, remains the leading cause of death and disability worldwide. Delays in diagnosis directly correlate with increased myocardial necrosis, higher ...
HeartBeam’s technology uniquely capable of assessing possible heart attacks outside of traditional clinical settings ALIGN-ACS study expected to complete patient enrollment quickly Milestone signifies ...
Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk ・Combines Mount Sinai’s world-class AI and ...
HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New ...
HeartBeam shares are trading higher Tuesday following a partnership with Mount Sinai to accelerate next-gen AI-ECG algorithms ...
HeartBeam (Nasdaq:BEAT) announced today that it entered into a strategic collaboration with the Icahn School of Medicine at Mount Sinai.
HeartBeam CEO Robert Eno and CFO Timothy Cruickshank will attend the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16-17, 2026. Management will host a presentation ...
The race to see which conference will place the most teams in the 2026 NCAA Tournament is coming down to the wire as Selection Sunday looms less than three weeks away. While the SEC currently leads ...
Abstract: Atrial fibrillation (A-Fib), a common cardiac arrhythmia, is linked to serious complications like heart failure and stroke, which early diagnosis could prevent. However, its paroxysmal and ...